From Celsus to Galen to Bone: The Illnesses, Syndromes, and Diseases of Acute Inflammation

  • J. C. Marshall
  • M. A. Aarts
Conference paper
Part of the Yearbook of Intensive Care and Emergency Medicine 2001 book series (YEARBOOK, volume 2001)


The evolution of intensive care has given rise to a unique challenge in medical taxonomy — to describe and characterize the course of diseases that have no biologic precedent. Intensivists debate the optimal definition of such common disorders as sepsis, the acute respiratory distress syndrome (ARDS), and multiple organ failure (MOF),but the roots of this debate he less in the inherent biologic vagaries of the individual processes than in the fact that they are, at root, iatrogenic creations. Acute lung injury only develops in patients whose death has been forestalled by the mechanical ventilator, while the profound physiologic derangements of overwhelming infection are rapidly lethal in the absence of fluid resuscitation, anti-infective therapy, and the spectrum of supportive measures that the contemporary intensive care unit (ICU) provides. The concept of the multiple organ dysfunction syndrome (MODS) reflects an implicit acceptance that the course of critical illness is defined more by what we as physicians have done to sustain the patient, than by the natural history of the extrinsic clinical disorders that rendered the patient critically ill.


Acute Lung Injury Systemic Inflammation Acute Respiratory Distress Syndrome Critical Illness Multiple Organ Dysfunction Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Endo S, Inada K, Yamada Y, et al (1995) Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22:949–955CrossRefGoogle Scholar
  2. 2.
    Hack CE, Hart M, Strack van Schijndel RJM, et al (1992) Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60:2835–2842PubMedGoogle Scholar
  3. 3.
    Friedland JS, Suputtamongkol Y, Remick DG, et al (1992) Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 60:2402–2408PubMedGoogle Scholar
  4. 4.
    Ghollet-Martin S, Montravers P, Gibert C, et al (1993) High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61:4553–4559Google Scholar
  5. 5.
    Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parrillo JE (1991) Endotoxemia in human septic shock. Chest 99:169–175PubMedCrossRefGoogle Scholar
  6. 6.
    Winchurch RA, Thupari JN, Munster AM (1987) Endotoxemia in burn patients: Levels of circulating endotoxins are related to burn size. Surgery 102:808–812PubMedGoogle Scholar
  7. 7.
    Brinkmann A, Wolf CF, Berger D, et al (1996) Perioperative endotoxemia and bacterial translocation during major abdominal surgery: Evidence for the protective effect of endogenous prostacyclin? Crit Care Med 24:1293–1301PubMedCrossRefGoogle Scholar
  8. 8.
    Mesters RM, Heiterbrand J, Utterback BG, et al (2000) Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med 28: 2209–2216PubMedCrossRefGoogle Scholar
  9. 9.
    Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2834:1038–1045CrossRefGoogle Scholar
  10. 10.
    Bernard GR, Hartman DL, Heiterbrand JD, Fisher GJ (1999) Recombinant human activated protein G (rhAPG) produces a trend toward improvement in morbidity and 28 day survival in patients with severe sepsis. Crit Care Med 27: A33 (Abst)CrossRefGoogle Scholar
  11. 11.
    Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A, for the ARDS Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  12. 12.
    Hebert PC, Wells G, Blajchman MA, et al (1999) A multicentre randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340:409–417PubMedCrossRefGoogle Scholar
  13. 13.
    Hayes MA, Yau EHS, Timmins AC, Hinds CJ, Watson D (1993) Response of critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption: relationship to outcome. Chest 103:886–895PubMedCrossRefGoogle Scholar
  14. 14.
    Connors AF Jr, Speroff T, Dawson NV, et al (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889–918PubMedCrossRefGoogle Scholar
  15. 15.
    Seely AJE, Christou NV (2000) Multiple organ dysfunction syndrome: Exploring the paradigm of complex non-linear systems. Crit Care Med 28:2193–2200PubMedCrossRefGoogle Scholar
  16. 16.
    Marshall JC (2000) Complexity, chaos, and incomprehensibihty: Parsing the biology of critical illness. Crit Care Med 28:2646–2648PubMedCrossRefGoogle Scholar
  17. 17.
    Majno G (1991) The ancient riddle of (Sepsis). J Infect Dis 163:937–945PubMedCrossRefGoogle Scholar
  18. 18.
    Long ER (1965) A History of Pathology. Dover Publications Inc, New YorkGoogle Scholar
  19. 19.
    Bone RC, Balk RA, Cerra FB, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655PubMedCrossRefGoogle Scholar
  20. 20.
    Meakins JL, Wicklund B, Forse RA, Mclean APH (1980) The surgical intensive care unit: current concepts in infection. Surg Clin North Am 60:117–132PubMedGoogle Scholar
  21. 21.
    Ziegler EJ, McCutchan JA, Fierer J, et al (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225–1230PubMedCrossRefGoogle Scholar
  22. 22.
    Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:654–658CrossRefGoogle Scholar
  23. 23.
    Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA, The Methylprednisolone Severe Sepsis Study Group (1989) Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389–393PubMedCrossRefGoogle Scholar
  24. 24.
    Casey LC, Balk RA, Bone RC (1993) Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771–778PubMedGoogle Scholar
  25. 25.
    Marshall JC (2000) Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med 26: S75–S83PubMedCrossRefGoogle Scholar
  26. 26.
    Bone RC (1991) Let’s agree on terminology: definitions of sepsis. Crit Care Med 19:973–976PubMedCrossRefGoogle Scholar
  27. 27.
    Sibbald WJ, Marshall JC, Christou NV, et al (1991) “Sepsis” — clarity of existing terminology … or more confusion? Crit Care Med 19:996–998PubMedCrossRefGoogle Scholar
  28. 28.
    Sprung CL (1991) Definitions of sepsis — have we reached a consensus? Crit Care Med 19: 849–851PubMedCrossRefGoogle Scholar
  29. 29.
    Vincent JL (1997) Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med 25:372–374PubMedCrossRefGoogle Scholar
  30. 30.
    Marshall JC, Baue AE (2000) SIRS and MODS: What is their relevance to the science and practice of critical care? Shock 14:586–589PubMedCrossRefGoogle Scholar
  31. 31.
    Dellinger RP, Bone RC (1998) To SIRS with love. Crit Care Med 26:178–179PubMedCrossRefGoogle Scholar
  32. 32.
    Bone RC (1996) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit Care Med 24: 163–172PubMedCrossRefGoogle Scholar
  33. 33.
    Bone RC (1996) A personal experience with SIRS and MODS. Crit Care Med 24:1417–1418PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • J. C. Marshall
  • M. A. Aarts

There are no affiliations available

Personalised recommendations